Ma S, Wang W, Su Y, Sun W, Ma L
Open Med (Wars). 2023; 18(1):20230644.
PMID: 37724125
PMC: 10505304.
DOI: 10.1515/med-2023-0644.
Ross J, Brittain C, Anstey Watkins J, Kai J, David M, Ozolins M
BMC Womens Health. 2023; 23(1):241.
PMID: 37161454
PMC: 10169495.
DOI: 10.1186/s12905-023-02303-5.
Gholiof M, Adamson-De Luca E, Wessels J
Front Reprod Health. 2022; 4:963752.
PMID: 36303679
PMC: 9580710.
DOI: 10.3389/frph.2022.963752.
Mollin A, Katta M, Sobel J, Akins R
PLoS One. 2022; 17(7):e0272012.
PMID: 35901180
PMC: 9333308.
DOI: 10.1371/journal.pone.0272012.
Chen X, Lu Y, Chen T, Li R
Front Cell Infect Microbiol. 2021; 11:631972.
PMID: 33898328
PMC: 8058480.
DOI: 10.3389/fcimb.2021.631972.
Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial: a mixed-methods approach.
Verwijs M, Agaba S, Umulisa M, Uwineza M, Nivoliez A, Lievens E
BMJ Open. 2020; 10(5):e031819.
PMID: 32434932
PMC: 7247375.
DOI: 10.1136/bmjopen-2019-031819.
Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing.
van de Wijgert J, Verwijs M, Agaba S, Bronowski C, Mwambarangwe L, Uwineza M
Sci Rep. 2020; 10(1):3884.
PMID: 32127550
PMC: 7054572.
DOI: 10.1038/s41598-020-60671-6.
Conventional oral and secondary high dose vaginal metronidazole therapy for recurrent bacterial vaginosis: clinical outcomes, impacts of sex and menses.
Sobel J, Kaur N, Woznicki N, Boikov D, Aguin T, Gill G
Infect Drug Resist. 2019; 12:2297-2307.
PMID: 31413606
PMC: 6661983.
DOI: 10.2147/IDR.S213853.
Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs M, Agaba S, Darby A, van de Wijgert J
Am J Obstet Gynecol. 2019; 222(2):157.e1-157.e13.
PMID: 31404542
PMC: 6995998.
DOI: 10.1016/j.ajog.2019.08.008.
Association Analysis on Recurrence of Bacterial Vaginosis Revealed Microbes and Clinical Variables Important for Treatment Outcome.
Xiao B, Wu C, Song W, Niu X, Qin N, Liu Z
Front Cell Infect Microbiol. 2019; 9:189.
PMID: 31245300
PMC: 6579829.
DOI: 10.3389/fcimb.2019.00189.
Prognostic Indicators of Recurrence of Bacterial Vaginosis.
Sobel J, Kaur N, Woznicki N, Boikov D, Aguin T, Gill G
J Clin Microbiol. 2019; 57(5).
PMID: 30842235
PMC: 6498020.
DOI: 10.1128/JCM.00227-19.
Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol.
Ma L, Su J, Su Y, Sun W, Zeng Z
BMJ Open. 2017; 7(10):e019301.
PMID: 29038188
PMC: 5706491.
DOI: 10.1136/bmjopen-2017-019301.
Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora.
Xiao B, Niu X, Han N, Wang B, Du P, Na R
Sci Rep. 2016; 6:26674.
PMID: 27253522
PMC: 4890590.
DOI: 10.1038/srep26674.
Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome.
Verstraelen H, Vervaet C, Remon J
PLoS One. 2016; 11(4):e0153441.
PMID: 27093291
PMC: 4836750.
DOI: 10.1371/journal.pone.0153441.
Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
Heczko P, Tomusiak A, Adamski P, Jakimiuk A, Stefanski G, Mikolajczyk-Cichonska A
BMC Womens Health. 2015; 15:115.
PMID: 26635090
PMC: 4669640.
DOI: 10.1186/s12905-015-0246-6.
Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.
Mendling W, Weissenbacher E, Gerber S, Prasauskas V, Grob P
Arch Gynecol Obstet. 2015; 293(3):469-84.
PMID: 26506926
PMC: 4757629.
DOI: 10.1007/s00404-015-3914-8.
Novel PCR-based methods enhance characterization of vaginal microbiota in a bacterial vaginosis patient before and after treatment.
Lambert J, Kalra A, Dodge C, John S, Sobel J, Akins R
Appl Environ Microbiol. 2013; 79(13):4181-5.
PMID: 23624483
PMC: 3697572.
DOI: 10.1128/AEM.01160-13.
Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda.
Vandepitte J, Weiss H, Bukenya J, Nakubulwa S, Mayanja Y, Matovu G
J Acquir Immune Defic Syndr. 2012; 62(1):119-26.
PMID: 23075920
PMC: 3529920.
DOI: 10.1097/QAI.0b013e3182777167.
Bacterial vaginosis, Atopobium vaginae and nifuratel.
Polatti F
Curr Clin Pharmacol. 2011; 7(1):36-40.
PMID: 22082330
PMC: 3362959.
DOI: 10.2174/157488412799218824.
Antibacterial treatment of bacterial vaginosis: current and emerging therapies.
Menard J
Int J Womens Health. 2011; 3:295-305.
PMID: 21976983
PMC: 3181210.
DOI: 10.2147/IJWH.S23814.